Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
about
PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.Thiazolidinediones in dermatology.Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.Metronomic chemotherapy: changing the paradigm that more is better.The Role of PPARs in the Endothelium: Implications for Cancer TherapyPeroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?Systems biology: a therapeutic target for tumor therapy.Prediction of high anti-angiogenic activity peptides in silico using a generalized linear model and feature selection
P2860
Q35458969-7F736049-1AFE-44A7-987F-5EA44397DE5EQ36615612-91EDAB97-8E33-4A9C-B1AE-99F0D4C6EF09Q36841072-F43A126B-1685-48C1-9007-75D44C93C5E5Q36964693-D5BB63FB-414E-4F21-870D-462E2F3AF295Q37157524-5F96D90B-3DA9-40E4-843E-3AF34106B508Q37158779-51A42D53-B831-4CC7-B7BD-3F7B8BD75444Q37337997-02C64222-EFDB-4196-8D81-F9DA0765785CQ38489705-23A1F8EC-2780-480C-A1C6-E7F558164F06Q41961938-CCC799A7-67E6-4465-9BDF-A65DE3AEE103Q57794760-95CD07EE-700F-4B44-98BF-87ECF45F2BCB
P2860
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antiangiogenic therapy with pi ...... t with endemic kaposi sarcoma.
@ast
Antiangiogenic therapy with pi ...... t with endemic kaposi sarcoma.
@en
type
label
Antiangiogenic therapy with pi ...... t with endemic kaposi sarcoma.
@ast
Antiangiogenic therapy with pi ...... t with endemic kaposi sarcoma.
@en
prefLabel
Antiangiogenic therapy with pi ...... t with endemic kaposi sarcoma.
@ast
Antiangiogenic therapy with pi ...... t with endemic kaposi sarcoma.
@en
P2093
P1433
P1476
Antiangiogenic therapy with pi ...... t with endemic kaposi sarcoma.
@en
P2093
Albrecht Reichle
Brigitte Coras
Christian Hafner
Michael Landthaler
Rolf-Markus Szeimies
Thomas Vogt
Ulrich Hohenleutner
P304
P356
10.1001/ARCHDERM.140.12.1504
P577
2004-12-01T00:00:00Z